Cargando…

Evaluation of diuretic efficiency of intravenous furosemide in patients with advanced heart failure in a heart failure clinic

INTRODUCTION: Diuretic efficiency (DE) is an independent predictor of all-cause mortality in acute heart failure (HF) at long-term follow-up. The performance of DE in advanced HF and the outpatient scenario is unclear. METHODS: Survival function analysis on a retrospective cohort of patients with ad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herrera-Leaño, Nancy, Barahona-Correa, Julián E., Muñoz-Velandia, Oscar, Fernández-Ávila, Daniel G., Mariño-Correa, Alejandro, Alberto García, Ángel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331187/ https://www.ncbi.nlm.nih.gov/pubmed/37417658 http://dx.doi.org/10.1177/17539447231184984

Ejemplares similares

Effectiveness of mobile telemonitoring applications in heart failure patients: systematic review of literature and meta-analysis
por: Rebolledo Del Toro, Martín, et al.
Publicado: (2023)

Dose of furosemide before admission predicts diuretic efficiency and long‐term prognosis in acute heart failure
por: Blázquez‐Bermejo, Zorba, et al.
Publicado: (2021)

Ambulatory intravenous furosemide for decompensated heart failure: safe, feasible, and effective
por: Ahmed, Fozia Z., et al.
Publicado: (2021)

Tolvaptan vs. furosemide‐based diuretic regimens in patients hospitalized for heart failure with hyponatremia (AQUA‐AHF)
por: Ng, Tien M.H., et al.
Publicado: (2020)

Diuretic Resistance in Heart Failure
por: Gupta, Richa, et al.
Publicado: (2019)

Prediction and measurement of diuretic responsiveness after oral administration of furosemide to healthy dogs and dogs with congestive heart failure
por: Loughran, Kerry A., et al.
Publicado: (2020)

Intravenous furosemide in decompensated heart failure: do not protocolize dosing but the desired effect!
por: de Grooth, Harm-Jan S, et al.
Publicado: (2014)

Diuretics as pathogenetic treatment for heart failure
por: Guglin, Maya
Publicado: (2011)

Optimal diuretic strategies in heart failure
por: Suri, Sarabjeet S., et al.
Publicado: (2021)

Diuretic Resistance Associated With Heart Failure
por: Shams, Elham, et al.
Publicado: (2022)

Clinical implication of initial intravenous diuretic dose for acute decompensated heart failure
por: Yoshioka, Kenji, et al.
Publicado: (2022)

Effects of intravenous furosemide plus small‐volume hypertonic saline solutions on markers of heart failure
por: Tuttolomondo, Antonino, et al.
Publicado: (2021)

Association of time‐to‐intravenous furosemide with mortality in acute heart failure: data from REPORT‐HF
por: Ouwerkerk, Wouter, et al.
Publicado: (2022)

‘Door-to-furosemide’ timing: early treatment of heart failure
por: Piazza, Vito
Publicado: (2019)

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
por: Velat, Ivan, et al.
Publicado: (2020)

Loop Diuretic Administration in Patients with Acute Heart Failure and Reduced Systolic Function: Effects of Different Intravenous Diuretic Doses and Diuretic Response Measurements
por: Ruocco, Gaetano, et al.
Publicado: (2019)

Role of Diuretics and Ultrafiltration in Congestive Heart Failure
por: Shchekochikhin, Dmitry, et al.
Publicado: (2013)

The Diuretic Effect of Theocalcin in Congestive Heart Failure
Publicado: (1931)

Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR‐AHF
por: Palazzuoli, Alberto, et al.
Publicado: (2017)

Outpatient treatment of worsening heart failure with intravenous and subcutaneous diuretics: a systematic review of the literature
por: Wierda, Eric, et al.
Publicado: (2020)

Decongestion: Diuretics and other therapies for hospitalized heart failure
por: Vazir, Ali, et al.
Publicado: (2016)

Tolvaptan: A Novel Diuretic in Heart Failure Management
por: Zulkifli Amin, Hilman, et al.
Publicado: (2016)

Diuretic dosing in heart failure: more data are needed
por: De Vecchis, Renato, et al.
Publicado: (2018)

Combined aquaretic and diuretic therapy in acute heart failure
por: Goyfman, Michael, et al.
Publicado: (2017)

Congestion and Diuretic Resistance in Acute or Worsening Heart Failure
por: Kristjánsdóttir, Ingibjörg, et al.
Publicado: (2020)

Diuretics in the management of chronic heart failure: when and how
por: Magdy, Joseph S, et al.
Publicado: (2022)

The Importance of the Nephrologist in the Treatment of the Diuretic-Resistant Heart Failure
por: Pethő, Ákos Géza, et al.
Publicado: (2023)

A Pharmacogenetic Investigation of Intravenous Furosemide in Decompensated Heart Failure: A Meta-Analysis of 3 Clinical Trials
por: de Denus, Simon, et al.
Publicado: (2016)

Proteomic differences among patients with heart failure taking furosemide or torsemide
por: Cooper, Lauren B., et al.
Publicado: (2022)

The Application of Dopamine Combined with Intravenous Furosemide Infusion Therapy Has an Apparent Clinical Effect in Treating Patients with Heart Failure
por: Shi, Jinzheng, et al.
Publicado: (2022)

Clinical Use of Diuretics in Heart Failure, Cirrhosis, and Nephrotic Syndrome
por: Qavi, Ahmed Hassaan, et al.
Publicado: (2015)

Effects of Empagliflozin on Diuretics Reduction in Outpatient Heart Failure Patients
por: Kim, Soo-Jin, et al.
Publicado: (2022)

Toward quantification of loop diuretic responsiveness for congestive heart failure
por: Oyama, Mark A., et al.
Publicado: (2022)

Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics
por: Yeoh, Su Ern, et al.
Publicado: (2023)

Addition of Tolvaptan Compared With Increased Dose of Furosemide in Heart Failure Patients With Chronic Kidney Disease Under Furosemide Treatment
por: Tanaka, Toshiki, et al.
Publicado: (2018)

Subcutaneous Furosemide in Heart Failure: Pharmacokinetic Characteristics of a Newly Buffered Solution
por: Sica, Domenic A., et al.
Publicado: (2018)

Association of early administration of furosemide with improved oxygenation in patients with acute heart failure
por: Mikami, Takafumi, et al.
Publicado: (2021)

Retracted: The Application of Dopamine Combined with Intravenous Furosemide Infusion Therapy Has an Apparent Clinical Effect in Treating Patients with Heart Failure
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Increased mortality in elderly heart failure patients receiving infusion of furosemide compared to elderly heart failure patients receiving bolus injection
por: Sager, Rana, et al.
Publicado: (2020)

Loop diuretics in acute heart failure: beyond the decongestive relief for the kidney
por: Palazzuoli, Alberto, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rck1p4q6u7jo1r939mnrbha84u